Baidu
map

BMJ:欧洲结直肠癌死亡率趋势——WHO死亡数据库的回顾性分析

2015-10-09 Mechront 译 MedSci原创

3

研究者对WHO死亡数据库进行回顾性分析,探究1970-2011年间欧洲34个国家结直肠癌死亡率的变化情况。纳入的死亡数据来自1970-2011年,不过1988年以后关于结直肠癌的筛查和治疗发生了深刻有效的变化;因此关于结直肠癌死亡率变化情况主要集中在1988年以后的时期。

1989-2011年间,欧洲34个国家的统计数据显示,结直肠癌的死亡率在男性人群中平均上升了6.0%,而在女性人群中则下降了14.7%。在奥地利、瑞士、德国、英国、比利时、捷克、卢森堡、爱尔兰这几个地区结直肠癌的死亡率在男性人群减少了25%,女性人群中减少了30%;不过在荷兰和瑞典,不论性别,结直肠癌的死亡率下降不到17%;同一时期,中欧地区的死亡率下降较低甚至没有下降。克罗地亚、前南斯拉夫马其顿共和国、罗马尼亚的男男女女和大多数东欧国家的男性因结直肠癌发生大量死亡。在死亡率下降的国家,对于女性任何年龄的死亡率的下降对于任何年龄的女性和<65岁的男性都很有意义。在27个欧盟成员国,结直肠癌男性死亡率下降了13%,女性下降27%;而美国的男女结直肠癌死亡率分别下降了39.8%和38.8%。

研究结果表明,在过去的40年里,欧洲不同国家结直肠癌死亡率情况已经有相当大的差距,并且不同性别不同年龄间差异也很大。结直肠癌死亡率下降最多的国家得益于其更好的筛查,尤其是内窥镜检查和专业的护理。

原始出处:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1847720, encodeId=7ee2184e720e0, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Nov 05 14:54:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50431, encodeId=cd235043104, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Wed Dec 30 12:55:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38908, encodeId=5d693890859, content=...., beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c891611001, createdName=wwwwwwww, createdTime=Thu Oct 15 09:29:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338953, encodeId=fd161338953fc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452770, encodeId=849a1452e7039, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516765, encodeId=a54c1516e6564, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]
    2015-11-05 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1847720, encodeId=7ee2184e720e0, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Nov 05 14:54:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50431, encodeId=cd235043104, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Wed Dec 30 12:55:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38908, encodeId=5d693890859, content=...., beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c891611001, createdName=wwwwwwww, createdTime=Thu Oct 15 09:29:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338953, encodeId=fd161338953fc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452770, encodeId=849a1452e7039, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516765, encodeId=a54c1516e6564, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]
    2015-12-30 xyfg98

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1847720, encodeId=7ee2184e720e0, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Nov 05 14:54:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50431, encodeId=cd235043104, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Wed Dec 30 12:55:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38908, encodeId=5d693890859, content=...., beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c891611001, createdName=wwwwwwww, createdTime=Thu Oct 15 09:29:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338953, encodeId=fd161338953fc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452770, encodeId=849a1452e7039, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516765, encodeId=a54c1516e6564, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]
    2015-10-15 wwwwwwww

    ....

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1847720, encodeId=7ee2184e720e0, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Nov 05 14:54:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50431, encodeId=cd235043104, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Wed Dec 30 12:55:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38908, encodeId=5d693890859, content=...., beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c891611001, createdName=wwwwwwww, createdTime=Thu Oct 15 09:29:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338953, encodeId=fd161338953fc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452770, encodeId=849a1452e7039, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516765, encodeId=a54c1516e6564, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1847720, encodeId=7ee2184e720e0, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Nov 05 14:54:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50431, encodeId=cd235043104, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Wed Dec 30 12:55:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38908, encodeId=5d693890859, content=...., beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c891611001, createdName=wwwwwwww, createdTime=Thu Oct 15 09:29:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338953, encodeId=fd161338953fc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452770, encodeId=849a1452e7039, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516765, encodeId=a54c1516e6564, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1847720, encodeId=7ee2184e720e0, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Nov 05 14:54:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=50431, encodeId=cd235043104, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Wed Dec 30 12:55:00 CST 2015, time=2015-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38908, encodeId=5d693890859, content=...., beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c891611001, createdName=wwwwwwww, createdTime=Thu Oct 15 09:29:00 CST 2015, time=2015-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338953, encodeId=fd161338953fc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452770, encodeId=849a1452e7039, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516765, encodeId=a54c1516e6564, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Oct 11 11:54:00 CST 2015, time=2015-10-11, status=1, ipAttribution=)]

相关资讯

招募患者:盐酸安罗替尼治疗转移性结直肠癌的IIb期临床研究

1.  试验药物简介 盐酸安罗替尼是小分子多靶点酪氨酸激酶抑制剂,本试验的目标人群是转移性结直肠癌患者。 2.  试验目的 与安慰剂联合最佳支持治疗对照,评价盐酸安罗替尼胶囊联合最佳支持治疗用于晚期结直肠癌患者的有效性和安全性。 3.  试验设计 试验分类:安全性和有效性 试验分期:II期 设计类型:平行分组(试验组:安罗替尼,对照组:安慰剂)

预防大肠癌的四个重要措施!

如何降低患大肠癌的风险?目前多数癌的病因并没有完全弄清楚,针对病因的一级预防措施有限,但这并不是说对此我们就无所作为,相当部分癌症的发病危险因素还是比较明确或基本弄明,癌症预防不妨就从这些癌症发病的危险因素着手。大肠癌的预防,先来了解一下与大肠癌发生有关的危险因素。大肠癌的病因和其他癌症一样,至今并未完全明了,以下几个因素可能与大肠癌的发病有关。首先来说遗传因素。据估计约20%的大肠癌患者中,遗传

CSCO 2015:陈功:精准医疗时代的个体化结直肠癌辅助化疗

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会在厦门举行。在今天的会议上,来自中山大学肿瘤防治中心的陈功教授做了题为《精准医疗时代的个体化结直肠癌辅助化疗》的报告。以下是陈功教授演讲内容:结直肠癌(colorectal cancer,CRC)是我国最常见的消化道恶性肿瘤之一,而且发病率和死亡率呈上升趋势。据2015年3 月发布的《2015 年中国肿瘤登记年报》数据显示,全国恶性肿瘤发病

FDA批准TAS-102(Lonsurf)用于治疗晚期结直肠癌

近日,美国食品药品监督管理局(FDA)批准了Lonsurf用于对其他治疗无应答的晚期结直肠癌患者(NEJM:TAS-102对难治性转移性结直肠癌的临床效果)(RECOURSE试验III期:TAS-102对比安慰剂治疗已给予最佳支持治疗且能耐受标准化疗的mCRC患者)。 Lonsurf是一种口服药,是三氟胸苷和 tipiracil 盐酸盐片,又称TAS-102,用于治疗已经化疗

Sci Rep:多吃鱼可降低结直肠的发病风险

Nature:多吃鱼可降低结直肠的发病风险近日,来自中山大学的一项研究表明,吃鱼可降低结直肠癌的发病率,该研究结果于8月25日在线发表于《Nature》。关于某些鱼的摄入与结直肠癌发病风险之间的关系仍存在争议。该项大型的队列研究旨在探讨中国人群某些鱼的摄入与结直肠癌发病风险之间的关系。研究纳入了2010年7月至2014年11月期间的1189 例结直肠癌患者以及1189名年龄性别与之匹配的对照者。以

Cell:模拟病毒感染带来癌症新疗法

近日,发表于国际杂志Cell上的一篇研究论文中,来自玛嘉烈公主癌症中心(Princess Margaret Cancer Centre)等处的研究人员通过对结直肠癌干细胞进行靶向研究阐明了一种模拟病毒的新机制,这或可潜在诱发免疫反应来抵御类似于感染引发的癌症。研究者De Carvalho说道,通过模拟病毒感染或许就可以诱骗机体免疫系统“看见”癌细胞,并且将癌细胞视作感染,进而就可以帮助清除癌细胞,

Baidu
map
Baidu
map
Baidu
map